The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors for myocarditis associated with immune checkpoint inhibitors using real-world clinical data.
 
Prantesh Jain
No Relationships to Disclose
 
Jahir Gutierrez Bugarin
No Relationships to Disclose
 
Avirup Guha
No Relationships to Disclose
 
Chhavi Jain
No Relationships to Disclose
 
Tingke Shen
No Relationships to Disclose
 
Ilya Stanevich
No Relationships to Disclose
 
Seunghee P Margevicius
No Relationships to Disclose
 
Pingfu Fu
No Relationships to Disclose
 
Fang Liu
No Relationships to Disclose
 
Vipan Nikore
Stock and Other Ownership Interests - Audicus; Cloud DX; Homecare Hub
 
Ankit Mangla
No Relationships to Disclose
 
Marcos J.G. De Lima
Consulting or Advisory Role - Celgene; Pfizer; Pharmacyclics
Research Funding - Celgene
 
Vamsidhar Velcheti
Consulting or Advisory Role - Alkermes; AstraZeneca/MedImmune; Boston Scientific; Bristol-Myers Squibb; Dr. Reddy's; Foundation Medicine; Genentech; Lilly; Merck; Nektar; Novartis
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai; Foundation Medicine; Merck
 
Jill Barnholtz-Sloan
No Relationships to Disclose
 
Afshin Dowlati
Consulting or Advisory Role - Abbvie/Stemcentrx; AstraZeneca; Bristol-Myers Squibb; Seagen; Takeda
Research Funding - Abbvie/Stemcentrx (Inst); Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Lilly/ImClone (Inst); Mirati Therapeutics (Inst); Regeneron (Inst); Seagen (Inst); Symphogen (Inst); Takeda (Inst); Tesaro (Inst); United Therapeutics (Inst)